In vitro uptake, anabolism, and cellular retention of 1843U89 and other benzoquinazoline inhibitors of thymidylate synthase

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3301-3306

  Hanlon, Mary H ^a,b   Ferone, Robert ^a  

^a Burroughs Wellcome Co   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 [[(1,2 DIHYDRO 3 METHYL 1 OXOBENZO[F]QUINAZOLIN 9 YL)METHYL]AMINO] 1 OXO 2 ISOINDOLINYL]GLUTARIC ACID; FOLYLPOLYGLUTAMATE SYNTHASE; QUINAZOLINE DERIVATIVE; RALTITREXED;

ARTICLE; CANCER CELL CULTURE; CECUM CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG RETENTION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; ILEUM CANCER; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; CARCINOMA; ENZYME INHIBITORS; FOLIC ACID; FOLIC ACID ANTAGONISTS; HUMANS; INDOLES; INTESTINAL NEOPLASMS; LEUCOVORIN; LIVER; METABOLIC CLEARANCE RATE; PEPTIDE SYNTHASES; POLYGLUTAMIC ACID; QUINAZOLINES; SWINE; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0029947689     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Duch, D. S. Banks, S., Dev, I. K , Dickerson, S. H., Ferone, R , Heath, L. S., Humphreys, J., Knick, V., Pendergast, W , Singer, S., Smith, G K , Waters, K., and Wilson, H. R Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase. Cancer Res., 53: 810-818, 1993
2. Jackman, A. L., Gibson W., Brown, M , Kimbell, R., and Boyle, F. T. The role of the reduced-folate carrier and metabolism to intracellular polyglutamates for the activity of ICI D1694 In: Y. M Rustum (ed), Novel Approaches to Selective Treatments of Human Solid Tumors: Laboratory and Clinical Correlation. Plenum Press, New York: 265-277, 1993.
3. Pendergast, W., Dickerson, S H., Dev, I. K., Ferone, R., Duch, D. S., and Smith, G. K. Benzo[f]quinazoline inhibitors of thymidylate synthase: methyleneamino-linked aroylglutamate derivatives J. Med. Chem , 37 838-844, 1994
4. Hanlon, M. H., Ferone, R., Weaver, K., and Ray, P. enzymatic synthesis of folate and antifolate polyglutamates with Escherichia coli folylpolyglutamate synthetase. Anal Biochem , 216: 345-351, 1994.
5. Hanlon, M. H., Ferone, R., Mullin, R. J., and Keith, B. R. In vivo and in vitro metabolism of 5-deazaacyclotetrahydrofolate, an acyclic tetrahydrofolate analogue. Cancer Res , 50: 3207-3211, 1990.
6. Lam, S., and Malikin, G. An improved micro-scale protein precipitation procedure for HPLC assay of therapeutic drugs in serum. J Liq Chromatogr , 12: 1851-1872, 1989.
7. Horne, D W , Krumdieck, C L., and Wagner, C. Properties of folic acid γ-glutamyl hydrolase (conjugase) in rat bile and plasma. J Nutr., 111: 442-449, 1981.
8. Jackman, A. L., Farrugia, W. G , Kimbell, R , Harrap, K. R., Stephens, T. C , Azab, M , and Boyle, F. T. ZD1694 (Tomudex): a new thymidylate synthase inhibitor with activity in colorectal cancer. Eur. J. Cancer, 31A: 1277-1282, 1995
9. Shane, B Folylpolyglutamate synthesis and role in the regulation of one-carbon metabolism. In: Vitamins and Hormones, Vol. 45, pp 263-335. New York: Academic Press, 1989
10. Fry, D W., Yalowich, and Goldman, I. D. Rapid formation of poly-γ-glutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cell in vitro. J. Biol. Chem., 257: 1890-1896, 1982
11. Sikora, E., Jackman, A L., Newell, D. R., and Calvert, A. H. Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB 3717) polyglutamates in L1210 cells in vitro Biochem. Pharmacol., 37: 4047-4054, 1988.
12. Ferone, R., Duch, D., Hanlon, M., Humphreys, J., See, C., Singer, S., and Waters, K. Potent inhibition of aminoimidazolecarboxamide ribotide transformylase (AICAR-TF) by polyglutamates of quinazoline thymidylate synthase (TS) inhibitors D1694 and CB3717. Proc. Am Assoc Cancer Res., 32: 326, 1991.
13. Smith, G K., Amyx, H , Boytos, C M., Duch, D. S , Ferone, R., and Wilson, H. R. enhanced antitumor activity for the thymidylate synthase inhibitor 1843U89 through decreased host toxicity with oral folic acid. Cancer Res., 55: 6117-6125, 1995
14. Ferone, R., Hanlon, M. H., Waters, K A , and Dev, I K Influence of intracellular polyglutamation on the cytotoxicity of the thymidylate synthase inhibitor 1843U89. Proc. Am. Assoc. Cancer Res., 34: 274, 1993
15. Zimmerman, J. Methotrexate transport in the human intestine: evidence for heterogeneity. Biochem. Pharmacol., 43: 2377-2383, 1992.
16. Zimmerman, J. Drug interactions in intestinal transport of folic acid and methotrexate further evidence for the heterogeneity of folate transport in the human small intestine Biochem. Pharmacol., 44: 1839-1842, 1992.
17. Dev, I. K., Dallas, W. S., Ferone, R., Hanlon, M , McKee, D. D., and Yates, B. B. Mode of binding of folate analogs to thymidylate synthase: evidence for two asymmetric but interactive substrate binding sites J. Biol. Chem., 269: 1873-1882, 1994.
18. Li, W. W., Tong, W. P., and Bertino, J. R Antitumor activity of antifolate inhibitors of thymidylate and purine synthesis in human soft tissue sarcoma cell lines with intrinsic resistance to methotrexate. Clin Cancer Res., 1: 631-636, 1995.
19. Jackman, A. L , Kelland, L. R., Kimbell, R., Brown, M , Gibson, W., Aherne, G. W , Hardcastle, and Boyle, F T. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. Br. J. Cancer, 71: 914-924, 1995.
20. Allegra, C. J , Chabner, B. A., Drake, J. C , Lutz, R., Rodbard, D., and Jolivet, J. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates J. Biol. Chem., 38: 355-362, 1989.
21. Chu, E , and Takimoto, C. H Antimetabolites In: V T Devita, Jr., S. Hellman, and S. A Rosenberg (eds), Cancer Principles and Practice of Oncology, Ed. 4, pp 358-362. Philadelphia: J. B. Lippincott Co., 1993.
22. 3-pteroylglutamates to dihydrofolate reductase. J. Clin. Invest , 72: 773-778, 1983
23. Sirotnak, F M., and DeGraw, J. I Selective antitumor action of folate analogs. In F. M. Sirotnak, J. J. Burchall, W. D Ensmunger, and J. A. Montgomery (eds), Folate Antagonists as Therapeutic Agents. Vol 2, pp. 43-95. New York: Academic Press 1984
24. Winick, N. J , Kamen, B A , and Balis, F. M Folate and methotrexate polyglutamate tissue levels in rhesus monkeys following chronic low-dose methotrexate Cancer Drug Delivery, 4: 25-29, 1987.
25. Chabner, B. A , Stoller, R. G., and Hande, K R. Methotrexate disposition in humans: case studies in ovarian cancer and following high-dose infusion. Drug Metab. Rev , 8 107-111, 1978
26. Marsham, P. R., Jackman, A L., Barker, A. J., Boyle, F. T., Pegg, S J., Wardleworth, J M., Kimbell, R., O'Connor, B. M , Calvert, A H , and Hughs, L R. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the c2-methyl series. J. Med. Chem , 38 994-1004, 1995.
27. Varney, M. D , Palmer, C. L , Deal, J G., Webber, S., Welsh, K. M., Bartlett, C A , Morse, C A , Smith, W. W., and Jansen, C A. Synthesis and biological evaluation of novel 2,6-diaminobenz[ad]indole inhibitors of thymidylate synthase using the protein structure as a guide. J. Med Chem., 38: 1892-1903, 1995